Get started
Author

Marina Toquero-Asensio

Observed names: M. Toquero-Asensio, Marina Toquero-Asensi, Marina Toquero‐Asensio
ORCID: 0009-0005-4569-6755
Observed ORCID: 0009-0005-4569-6755
OpenAlex ID: A5092930603
Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024
2024 · Mónica López-Lacort, Cintia Muñoz-Quiles, et al. · Eurosurveillance · 282
PDF
RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022
2024 · Mariana Haeberer, Martin Mengel, et al. · Infectious Diseases and Therapy · 24
PDF
The Impact of the COVID-19 Pandemic on Influenza Vaccination Attitudes and Actions in Spain’s Adult Population
2023 · Camino Prada-García, Marina Toquero-Asensio, et al. · Vaccines · 15
PDF
Disease burden of influenza in Spain: A five-season study (2015–2020)
2025 · Iván Sanz-Muñoz, Irene Arroyo-Hernantes, et al. · Human Vaccines & Immunotherapeutics · 14
A 15-year study of neuraminidase mutations and the increasing of S247N mutation in Spain
2025 · Iván Sanz-Muñoz, Alejandro Martín-Toribio, et al. · Virus Research · 6
Respiratory Syncytial Virus Risk Profile in Hospitalized Infants and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022
2024 · Mariana Haeberer, Martin Mengel, et al. · Infectious Diseases and Therapy · 6
PDF
Epidemiology of rhinovirus/enterovirus infection in hospitalized patients
2025 · B. Lopez-Villalba, L. Tejedor-Cantero, et al. · Revista Clínica Española (English Edition) · 3
Analyzing Changes in Attitudes and Behaviors towards Seasonal Influenza Vaccination in Spain’s Adult Population over Three Seasons
2024 · Camino Prada-García, Marina Toquero-Asensio, et al. · Vaccines · 3
Epidemiología de la infección por rinovirus/enterovirus en pacientes hospitalizados
2025 · B. Lopez-Villalba, L. Tejedor-Cantero, et al. · Revista Clínica Española · 2
Characteristics and Risk Factors Associated With Hospitalization and Severe Disease in Patients Aged ≥ 60 Years With Human Metapneumovirus Infection Over Three Consecutive Seasons (2021–2024) in Valladolid, Spain. The VALLAVIRUS Study
2026 · Iván Sanz‐Muñoz, Silvia Galindo‐Carretero, et al. · Influenza and Other Respiratory Viruses · 1
Incidence, Complications, and Quality of Life in Adults ≥ 60 Years Old With Laboratory‐Confirmed RSV Infections Attended in Primary Care and in Hospitals: A Study Over Three Seasons in Valladolid, Spain
2026 · Iván Sanz‐Muñoz, Raquel Iglesia‐Aparicio, et al. · Influenza and Other Respiratory Viruses · 1
A Sequence‐Based Update on Amino Acid Substitutions in Influenza Polymerase Acidic Protein in Europe That Alter Baloxavir Susceptibility From 2009 to 2025
2026 · Alejandro Martín‐Toribio, Inés Inchausti‐Moya, et al. · Influenza and Other Respiratory Viruses
Neuraminidase-Based Cross-Protective Immunity against H5N1 Influenza Viruses in Humans
2026 · Iván Sanz-Muñoz, Carlos J. Ciria-Gil, et al. · bioRxiv (Cold Spring Harbor Laboratory)
EE588 Direct Costs of RSV Cases in Hospitalized Patients (Aged ≥60 Years) Identified From 2010-2020 in a Retrospective Study in Valladolid, Spain
2024 · I. Sanz-Muñoz, J. Sanchez-Martinez, et al. · Value in Health
PDF
EE751 Direct Costs of RSV Cases (2022-2023 and 2023-2024 Seasons) in Hospitalized Patients and Out-Patients (Aged ≥60 Years) Prospectively Identified in Valladolid, Spain
2024 · I. Sanz-Muñoz, J. Sanchez-Martinez, et al. · Value in Health
PDF
Works count: 15
Citation count: 357
H-index: 6
I10-index: 4
Year
Topic
Type